跳至主要内容
临床试验/ISRCTN41705277
ISRCTN41705277
已完成
未知

The effect of muscle relaxant drugs on the larynx

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 40 人2004年1月23日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Ear, nose and throat diseases
发起方
HS R&D Regional Programme Register - Department of Health (UK)
入组人数
40
状态
已完成
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2004年1月23日
结束日期
1999年1月31日
最后更新
6年前
研究类型
Interventional

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

入排标准

入选标准

  • Phase 1: 40 patients will be studied in this randomised crossover study. All patients will be scheduled to undergo elective surgery which will require the use of nondepolarizing muscle relaxants.
  • Phase 2: American Society of Anesthesiologists (ASA) 1\&2 patients will be studied initially. Inclusion and exclusion criteria and patient monitoring will be as for Phase 1\. Patients will then be allocated randomly to receive one of five muscle relaxants (10 per group). If numbers prove insufficient, further patients will be recruited, in groups of 25 (5 per group).

排除标准

  • Any patient with a history of regurgitation, dyspepsia or neuromuscular disease or who is taking any medication that may interfere with neuromuscular function will be excluded.

结局指标

主要结局

未指定

相似试验